HSPH-Merck Workshop

Program

HSPH FEATURES

Children's health

Progress, challenges in raising educated and healthy girls

Healthy eating

Creating healthy, sustainable food choices

Draft Program

Please check back for additional updates (last updated 6/1/2012)

Thursday, May 31

Snyder Auditorium, Kresge G-1
8:00-8:30  Registration & Breakfast (Snyder Auditorium)

SESSION I
8:30-9:15
 Welcome & IntroductionsVictor DeGruttola & Marcia A. Testa, Harvard School of Public Health
Research in Action: Putting the Patient at the Center of Care Carolyn M. Clancy, Agency for Healthcare Research and Quality
SESSION II – CER in Medical Product Development: The role of pragmatic randomized trials, large simple trials, observational studies and models
 9:15-10:30
 Session Chairs: John Cook & Nancy Santanello, Merck Research Laboratories
  CER in Medical Product Development: Role of Non-Interventional Study Designs from an Industry Perspective     

Cynthia J. Girman, Merck Research Laboratories
Comparative Effectiveness ResearchRobert Temple, Food & Drug Administration
CER in Medical Product Development: Person, Place and TimeAdrian Levy, Department of Community Health & Epidemiology, Dalhousie University
10:30-10:45 Break
SESSION III – Methodological advances for difficult questions in CER                                                                      
10:45-12:15 Session Chair: Sebastian Schneeweiss, Harvard School of Public Health
  Statistical Considerations When Combining Data for Comparative Effectiveness Research
Sharon-Lise Normand, Harvard Medical School/School of Public Health
Thou Shalt Not Include Prevalent Users. Asking the right questions in comparative effectiveness researchMiguel Hernán, Harvard School of Public Health
  Comparative Effectiveness in the Presence of Competing RisksLee-Jen Wei, Harvard School of Public Health
12:15-1:15 Lunch (Sebastian’s Cafe, Kresge 1st Floor)
SESSION IV- Patients & Payors                                       
1:15-2:15  Advancing Analytics for Technology-Enabled Patient-Centered Outcomes ResearchSession Chair: Marcia A. Testa, Harvard School of Public Health
Cost-Effectiveness and Comparative Effectiveness: Can They Be Separated? Milton C. Weinstein, Harvard School of Public Health
 
SESSION V - Methodological Tools for Assessing Cause and Effect
2:15-3:45 Session Chair: Sharon-Lise Normand,Harvard Medical School/School of Public Health
Making the best of secondary healthcare data: Improved confounding control for CER with claims and EHR databasesSebastian Schneeweiss, Harvard School of Public Health
Systematic Reviews of Comparative Effectiveness ResearchSally C. Morton, University of Pittsburgh
Comparative Effectiveness based on Long-Term Outcomes: The Role of Simulation ModelsCarolyn M. Rutter, Group Health Research Institute
3:45-4:00 Break
SESSION VI – Presentation of Case Studies
4:00-5:00  When to start antiretroviral therapy? Comparative effectiveness of dynamic regimesMiguel Hernán & Lauren Cain, Harvard School of Public Health
Comparative Effectiveness of Revascularization StrategiesLaura Mauri, Brigham & Women’s Hospital
Randomized field trial of Cardiac Computed Tomography Angiography (CCTA) to rule out acute coronary syndrome (ACS) in the emergency departmentDavid A. Schoenfeld, Harvard School of Public Health
5:00-6:00 Reception (Sebastian’s Cafe, Kresge 1st Floor)
 

Friday, June 1

SESSION VII

Sebastian’s Cafe, Kresge 1st Floor
8:00-8:30 Breakfast
8:30-9:45  Small Group Discussions
9:45-10:00 Break
SESSION VIII

Snyder Auditorium, Kresge G-1
10:00-10:30  Plenary Discussion
10:30-10:45  Closing RemarksMarcia A. Testa, Harvard School of Public Health

 Marvin Zelen Leadership Award in Statistical Science
11:00-12:00  Nicholas P. JewellSnyder Auditorium, Kresge G-1 Counting Civilian Casualties
12:00-1:00 Luncheon Reception Sebastian’s Cafe, Kresge 1st Floor